NCT01660815View on ClinicalTrials.gov

A Study of Florbetapir (18F) in Japanese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Alzheimer's Disease
Interventions
DRUG

florbetapir (18F)

IV injection, 370 MBq (10mCi), single dose

Trial Locations (1)

Unknown

Research Site, Kobe

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Avid Radiopharmaceuticals

INDUSTRY